Sort
261,768 grants matching “gene therapy”
Genetic Susceptibility to Pediatric Glioma inIndividuals and Diverse populations
$988,381Joseph Leo Wiemels · University Of California, San Francisco · R01 · FY2015 · CA
A novel vaccine against mosquito-borne Zika virus based on mosquito salivary gland protein AgBR1
$988,360Erol Fikrig · L2 Diagnostics, Llc · R42 · FY2022 · AI
A small molecule broad spectrum inhibitor of antiapoptotic genes to treat cancer
$988,326Xiang Ling · Canget Biotekpharma, Llc · R44 · FY2016 · CA
TULANE NATINAL PRIMATE RESEARCH CENTER
$988,254Benjamin Paul Sachs · Tulane University Of Louisiana · P51 · FY2007 · RR
AsthmaNet: Brigham and Women's Hospital & Children's Hospital Boston
$988,251Elliot Israel · Brigham And Women'S Hospital · U10 · FY2011 · HL
Integrative Resource to Develop Translational Strategies to Promote Longevity
$988,213Steven R Cummings · California Pacific Med Ctr Res Institute · U24 · FY2016 · AG
Xenobiotic Receptors
$988,205Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Improved Diagnosis and Treatment of Cushing's Disease
$988,203Prashant Chittiboina · National Institute Of Neurological Disorders And Stroke · ZIA · FY2016 · NS
Roles of tumor suppressors (TSs) in metastatic progression
$988,119Li Yang · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Metabolomics of subclinical and clinical cardiovascular disease
$988,004Dean P. Jones · Emory University · P20 · FY2015 · HL
Molecular brush-conjugated antisense oligonucleotide as a pan-KRAS depletion agent
$988,000Ke Zhang · Pacdna Llc · R42 · FY2024 · CA
Clonotyping Technology for Prediction of Antibiotic Resistance
$987,986Evgeni Veniaminovic Sokurenko · Idgenomics, Inc. · R42 · FY2017 · AI
Novel Biguanides to Treat Type 2 Diabetes
$987,938Ken W Batchelor · Novatarg, Inc. · R44 · FY2016 · DK
Humanized monoclonal antibodies to treat mucormycosis
$987,901Gary Lazar · Vitalex Biosciences, Llc · R44 · FY2023 · AI
The Microbial Ecology of Bacterial Vaginosis: A Fine Scale Resolution Metagenomic
$987,891Jacques Ravel · University Of Maryland Baltimore · UH2 · FY2009 · AI
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
$987,871Suresh Ambudkar · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Ebola Vaccine Development
$987,868Nancy J Sullivan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Polymerase epsilon-based mouse and derived organoid models of intestinal cancer
$987,867Diego H Castrillon · Ut Southwestern Medical Center · R01 · FY2025 · CA
Therapeutic Strategy to slow progression of calcific aortic valve stenosis
$987,837Jordan D Miller · Mayo Clinic Rochester · UH2 · FY2013 · TR
Leveraging natural phenotypic variations of heterogenous ALS populations-in-a-dish to enable scalable drug discovery
$987,822Justin Kawika Ichida · University Of Southern California · R01 · FY2023 · NS
Screening for rAAV transduction enhancers
$987,813Terry L Bowlin · Microbiotix, Inc · R44 · FY2023 · AI
Arizona Center for Education and Research on Therapeutics
$987,764Raymond L Woosley · Critical Path Institute · U18 · FY2010 · HS
Genetic modifiers of Duchenne Muscular Dystrophy
$987,747Kevin M Flanigan · Research Inst Nationwide Children'S Hosp · R01 · FY2014 · NS
Optimization of novel pyranopyridine efflux pump inhibitors
$987,681Timothy J Opperman · Microbiotix, Inc · R44 · FY2019 · AI
GENE THERAPY STRATEGIES FOR SICKLE CELL DISEASE
$987,595University Of California San Francisco · P01 · FY2001 · HL